MTOR and neoplasm: Recently, the protein kinase B (AKT)/mammalian target of rapamycin (mTOR) signal pathway is over-activated in numerous tumors, including NSCLC, and associated with tumor angiogenesis, invasion, metastasis and so on [5–7].